Myqorzo and Redemplo approved in China Approval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndromeUnderscores Sanofi’s long-term commitment to ...
Myqorzo and Redemplo approved in China Approval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndromeUnderscores Sanofi's long-term commitment to ...
Vojislav Gligorovski is one of only six recipients of the global International Birnstiel Award for Doctoral Research in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback